-
Naclerio R, Proud D, Togias A, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985;313:65-70.
-
Naclerio R. Pathophysiology of perennial allergic rhinitis. Allergy 1997;52 (suppl36):S7-S13.
-
Sampson H. Adverse Reactions to Foods. In: Middleton E, Reed C, Ellis E, Adkinson F, Yunginger J, Busse W, editors. Allergy. St Louis: Mosby, 1998:1162-1182.
-
National Institute of Allergy and Infectious Diseases, National Institutes of Health. Food Allergy and Intolerances, January 1999.
-
Platts-Mills T, Woodfolk J, Vaughan J. Allergen Avoidance What Work, What Doesn?t. Proceedings of the 54th Am. Academy of Allergy, Asthma and Inmunology: 1998 Mar 13-18; Washington, D.C. AAAA&I, 1998.
-
Church M, Holgate S, Shute J, Walls A, Sampson A. Mast Cells-Derived Mediators. In: Middleton E, Reed C, Ellis E, Adkinson F, Yunginger J, Busse W, editors. Allergy. St Louis: Mosby, 1998:146-167.
-
Dykewicz M, Fineman S. Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. Ann Allergy Asthma Inmunol 1998;81:463-68
-
Simons E, Simons K. The Pharmacology and Use of H1 Receptor-Antagonist Drugs. New Engl J Med 1994;330: 1663-70
-
Simons E. H1-Receptor Antagonist. Comparative Tolerability and Safety. Drug Safety 1994;10 (5):350-80
-
Songzhu An, Goetzl E. Lipid Mediators of Hypersensitivity and Inflammation. In: Middleton E, Reed C, Ellis E, Adkinson F, Yunginger J, Busse W, editors. Allergy. St Louis: Mosby, 1998:168-182.
-
Wenzel S. Arachidonic Acid Metabolites. Pharmacotherapy 1997;17:S3-S12.
-
Taylor I. Measurements of Leukotrienes in Asthma: In Holgate S, Dahlén S, editors. SRS-A to Leukotrienes. London: Blackweel Science Ltd.,1997:203-234
-
Rouadi P, Naclerio R. Leukotrienes as Mediators in the Nose: In Holgate S, Dahlén S, editors. SRS-A to Leukotrienes. London: Blackweel Science Ltd.,1997: 301-320.
-
Prenner B. The Potential Benefits of Leukotriene Antagonist and Antihistamines on the Upper Airway. Proceedings of the 55th Am. Academy of Allergy, Asthma and Inmunology: 1999 Feb 27; Orlando Fla. AAAA&I, 1999.
-
Norris A, Holgate S. Cromolyn Sodium and Nedocromil Sodium. In: Middleton E, Reed C, Ellis E, Adkinson F, Yunginger J, Busse W, editors. Allergy. St Louis: Mosby, 1998:661-667.
-
Letari O, Miozzo A, Folco G, BelloniP, Sala A, et al. Effects of Loratadina on Cytosolic Ca2+ Levels and Leucotriene Release: novel mechanism of action independent of the anti-histaminic activity. Eur J Pharmacol 1994;266:219-227.
-
Patella G, Crescenza G, Paulis A, Spadaro G, Marone G. Loratadina and Desethoxylcarbonyl-loratadina Inhibit the Immunological Release of Mediators from Human FceRI+ Cells. Clin Exp Allergy 1997;27:559-567.
-
Kalayci O, Adalioglu G, Sekerel B, Tuncer A. The Effects of Cetirizine on Sulfidoleukotriene Production by Blood Leukocytes in Children with Allergic Rhinitis. Allergy 1995;50:964-969.
-
Church M, Levi-Schaffer F. The Human Mast Cell. J Allergy Clin Immunol 1997;99:155-60
-
Howarth P. Allergic Mechanisms in Rhinitis. Proceedings of the 53th Am. Academy of Allergy, Asthma and Inmunology: 1997 Feb24; San Francisco. AAAA&I.
-
Aldrey O, Moléculas de Adhesión. Publicación Centro Nacional de Inmunología Clínica MSAS/UCV. Instituto de Inmunología UCV. Caracas 1998.
-
Galli S, Lantz C. Allergy. In: Paul W, editor. Fundamental Inmunology. Philadelphia: Lippincott-Raven, 1999:1127-1174.
-
Canonica G, Cipriani G, Passalacqua G, Pesce G, et al. Molecular Events in Allergic Inflammation: Experimental Models and Possible Modulation. Allergy 1997;52 (suppl 34):25-30.
-
Bousquet J, Czarlewski W, Danzin M. Antiallergic Properties of Loratadine: A Review. Advances in Therapy 1995;12 (5):283-298.
-
Barnes P, Pedersen S, Busse W. Efficacy and Safety of Inhaled Corticosteroids. Am J Respir Crit Care Med 1998;157:S1-S53.
-
International Rhinitis Management Working Group. International Consensus Report on the Diagnosis and Management of Rhinitis. Allergy 1994;49 (suppl 19):1-34.
-
European Academy of Allergology and Clinical Immunology. The Impact of Allergic Rhinitis on Quality of Life and Other Airway Diseases. Allergy 1998;53 (suppl. 41):7-31
-
Meltzer E. Evaluating Rhinitis. J Allergy Clin Immunol 1988;82:900-8.
-
Juniper E. Impact of Upper Respiratory Allergic Diseases on Quality of Life. J Allergy Clin Immunol 1998;101: S386-391.
